Search hospitals > Iowa > Des Moines
Iowa Methodist Medical Center
Claim this profileDes Moines, Iowa 50309
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
347 reported clinical trials
4 medical researchers
Summary
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Adenocarcinoma, Lung Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 492 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Global LeaderStage IV
Stage III
Stage I
Top PIs
Joshua LukenbillMedical Oncology and Hematology Associates-Des Moines4 years of reported clinical research
Expert in Cancer
Expert in Tumors
140 reported clinical trials
215 drugs studied
Samantha L. MalloryBlank Children's Hospital7 years of reported clinical research
Expert in Tumors
Expert in Brain Tumor
53 reported clinical trials
102 drugs studied
Robert J. BehrensIowa Methodist Medical Center4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
43 reported clinical trials
97 drugs studied
Joshua LuckenbillIowa Methodist Medical Center3 years of reported clinical research
Studies Head and Neck Cancers
1 reported clinical trial
1 drug studied
Clinical Trials running at Iowa Methodist Medical Center
Cancer
Breast Cancer
Squamous Cell Carcinoma
Prostate Cancer
Gastric Cancer
Non-Small Cell Lung Cancer
Gastroesophageal Junction Adenocarcinoma
Lung Cancer
Esophageal Cancer
Bladder Cancer
Reduced-Intensity Chemoradiation
for Anal Cancer
This phase II trial studies how well lower-dose chemotherapy plus radiation (chemoradiation) therapy works in comparison to standard-dose chemoradiation in treating patients with early-stage anal cancer. Drugs used in chemotherapy, such as mitomycin, fluorouracil, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving chemotherapy with radiation therapy may kill more tumor cells. This study may help doctors find out if lower-dose chemoradiation is as effective and has fewer side effects than standard-dose chemoradiation, which is the usual approach for treatment of this cancer type.
Recruiting3 awards Phase 25 criteria
Behavioral Therapy vs. Healthy Eating Education
for Cancer-Related Insomnia
This phase III trial compares BBT-CI to HEAL for the reduction of insomnia in patients with stage I-IV cancer who are receiving cancer treatment. Cancer treatment can cause side effects such as sleep problems. Sleep problems such as insomnia, are common for cancer patients. Insomnia can be described as difficulty falling asleep, waking up many times during the night or waking up earlier than patient would like. Insomnia can increase fatigue and worsen quality of life. This trial may help researchers determine which treatment works better in reducing insomnia, BBT-CI or HEAL.
Recruiting2 awards Phase 33 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Iowa Methodist Medical Center?
Iowa Methodist Medical Center is a medical facility located in Des Moines, Iowa. This center is recognized for care of Cancer, Recurrence, Breast Cancer, Adenocarcinoma, Lung Cancer and other specialties. Iowa Methodist Medical Center is involved with conducting 347 clinical trials across 492 conditions. There are 4 research doctors associated with this hospital, such as Joshua Lukenbill, Samantha L. Mallory, Robert J. Behrens, and Joshua Luckenbill.
Where is Iowa Methodist Medical Center located?
**Iowa Methodist Medical Center Visitor Information:**
To reach the Iowa Methodist Medical Center in Des Moines, Iowa, exit I-235 at Keo Way south, turn right onto 12th Street, and follow the road up the hill to the campus. Visitor parking is available on both the north and south sides of the campus, as well as in the parking ramp on the west side.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Iowa Methodist Medical Center, part of UnityPoint Health:
- Contact the Central Billing Office at (844) 849-1260 or email FA_CBO_Request@unitypoint.org for policy details and application assistance.
- For insurance matters and payment options, bring your ID, insurance card, and driver's license to admitting/registration, or inquire about the Helping Hand Loan Program.
- If you're facing difficulties paying your bill, reach out to the UnityPoint Health Billing Department at 1-844-849-1260 for support.
What insurance does Iowa Methodist Medical Center accept?
The Iowa Methodist Medical Center, located in Des Moines, Iowa, is part of UnityPoint Health. It has partnerships with various insurance companies, including HealthPartners, Medica, and Wellmark Blue Cross and Blue Shield of Iowa, suggesting these plans may be accepted. For a definitive list of accepted insurance plans, contact the hospital directly or visit their official website.
What awards or recognition has Iowa Methodist Medical Center received?
Iowa Methodist Medical Center has been endowed with $1 million for its Director position, highlighting its commitment to excellence. It is ranked #3 in Iowa and recognized in Central Iowa by U.S. News & World Report. The hospital also features a Virtual Research Data Center (VRDC), showcasing its dedication to advancing medical research.